University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

EMA and NICE Appraisal Processes for Cancer Drugs : Current Status and Uncertainties

dc.contributor.authorDickson, Rumona
dc.contributor.authorBoland, Angela
dc.contributor.authorDuarte, Rui
dc.contributor.authorKotas, Eleanor
dc.contributor.authorWoolacott, Nerys
dc.contributor.authorHodgson, Robert
dc.contributor.authorRiemsma, Rob
dc.contributor.authorGrimm, Sabine
dc.contributor.authorRamaekers, Bram
dc.contributor.authorJoore, Manuela
dc.contributor.authorBüyükkaramikli, Nasuh
dc.contributor.authorKaltenthaler, Eva
dc.contributor.authorStevenson, Matt
dc.contributor.authorPandor, Abdullah
dc.contributor.authorEdwards, Steve
dc.contributor.authorHoyle, Martin
dc.contributor.authorShepherd, Jonathan
dc.contributor.authorArmoiry, Xavier
dc.contributor.authorBrazzelli, Miriam
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Evaluationen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2019-02-06T15:50:08Z
dc.date.available2019-02-06T15:50:08Z
dc.date.issued2018-08
dc.descriptionThe Evidence Review Group members that contributed to this editorial are funded by the UK NIHR HTA Programme. The views and opinions expressed are those of the authors and do not necessarily reflect those of the UK Department of Health and the NIHR.en
dc.description.statusPeer revieweden
dc.format.extent4
dc.format.extent418311
dc.identifier141971311
dc.identifier673e322a-75b8-4c4e-8dbf-b9da5c88a148
dc.identifier29808296
dc.identifier85047664700
dc.identifier.citationDickson, R, Boland, A, Duarte, R, Kotas, E, Woolacott, N, Hodgson, R, Riemsma, R, Grimm, S, Ramaekers, B, Joore, M, Büyükkaramikli, N, Kaltenthaler, E, Stevenson, M, Pandor, A, Edwards, S, Hoyle, M, Shepherd, J, Armoiry, X & Brazzelli, M 2018, 'EMA and NICE Appraisal Processes for Cancer Drugs : Current Status and Uncertainties', Applied Health Economics and Health Policy, vol. 16, no. 4, pp. 429-432. https://doi.org/10.1007/s40258-018-0393-7en
dc.identifier.doi10.1007/s40258-018-0393-7
dc.identifier.iss4en
dc.identifier.otherPubMedCentral: PMC6028888
dc.identifier.urihttp://hdl.handle.net/2164/11875
dc.identifier.vol16en
dc.language.isoeng
dc.relation.ispartofApplied Health Economics and Health Policyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectH Social Sciencesen
dc.subject.lccHen
dc.titleEMA and NICE Appraisal Processes for Cancer Drugs : Current Status and Uncertaintiesen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
EMA_and_NICE_Appraisal_Processes_for_Cancer_Drugs.pdf
Size:
408.51 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description: